SAN DIEGO–(BUSINESS WIRE)–FairJourney Bio (“FJBio”), a global antibody discovery expert, has entered a partnership with AbTherx, Inc. to bring transgenic mouse-based antibody discovery in-house. The agreement gives the Company access to AbTherx’s Atlas™ Full Human Diversity (FHD) and Common Light Chain (cLC) mouse technologies, completing a discovery route that partners can now run end to end entirely within FJBio’s integrated workflow. From the partnership, a programme can now move from immu
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
